Promising Medical Stocks To Add to Your Watchlist - June 26th

Hims & Hers Health, UnitedHealth Group, and Eli Lilly and Company are the three Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of publicly traded companies that operate in the healthcare sector—this includes pharmaceutical manufacturers, biotechnology firms, medical device makers, diagnostic laboratories and healthcare service providers. By buying these stocks, investors gain partial ownership in firms whose revenues and valuations often hinge on factors like drug approvals, clinical trial results and advances in medical technology. Their performance can be influenced by regulatory decisions, healthcare policies and demographic trends. These companies had the highest dollar trading volume of any Medical stocks within the last several days.

Hims & Hers Health (HIMS)

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

NYSE HIMS traded up $4.35 during mid-day trading on Thursday, hitting $45.76. The company's stock had a trading volume of 41,321,089 shares, compared to its average volume of 22,730,366. The firm has a market capitalization of $10.24 billion, a price-to-earnings ratio of 66.30, a PEG ratio of 1.62 and a beta of 2.09. The company's 50 day simple moving average is $49.27 and its 200 day simple moving average is $39.37. Hims & Hers Health has a twelve month low of $13.47 and a twelve month high of $72.98.

Read Our Latest Research Report on HIMS

UnitedHealth Group (UNH)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

NYSE UNH traded up $1.46 on Thursday, reaching $303.48. The company had a trading volume of 3,649,832 shares, compared to its average volume of 7,388,563. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. The company's fifty day moving average is $342.22 and its 200 day moving average is $458.07. UnitedHealth Group has a 52-week low of $248.88 and a 52-week high of $630.73. The stock has a market capitalization of $275.30 billion, a P/E ratio of 12.70, a P/E/G ratio of 1.45 and a beta of 0.44.

Read Our Latest Research Report on UNH

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

Shares of LLY traded up $2.82 on Thursday, reaching $795.12. 1,305,688 shares of the company's stock traded hands, compared to its average volume of 3,661,094. The stock's 50 day simple moving average is $782.41 and its two-hundred day simple moving average is $800.16. The company has a current ratio of 1.37, a quick ratio of 1.06 and a debt-to-equity ratio of 2.18. Eli Lilly and Company has a 52-week low of $677.09 and a 52-week high of $972.53. The stock has a market cap of $753.56 billion, a PE ratio of 64.72, a PEG ratio of 1.14 and a beta of 0.40.

Read Our Latest Research Report on LLY

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.